Hematologie nieuws
- Frequency of red blood cell phenotypes from genotyped Australian blood donors
- Sanofi's LUNA 3 phase 3 study of rilzabrutinib in patients with immune thrombocytopenia meets primary endpoint
- Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia
- How do we leverage data through replication and warehousing to meet blood collection and transfusion service needs
- Absence of evidence of transfusion transmission risk of Creutzfeldt?Jakob disease in the United States: Results froma 28?year lookback study
- Use of automated haematology analysers for the quality control of blood components for transfusion: Comment on Valina et al. (Transfusion Medicine 2024;34:30–38)
- Surgical patients' perception about risks related to blood transfusion: A cross?sectional survey
- Performance of direct oral anticoagulant (DOAC) testing by hemostasis laboratories: The Australasian/Asia?Pacific experience
- New method to differentiate between lupus anticoagulants, progressive coagulation inhibitors and coagulation factor deficiencies in the mixing tests
- Thirty years of experience with solvent/detergent?treated plasma for transfusion medicine
- Immune reconstitution in children after haploidentical haematopoietic stem cell transplantation
- Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management
- ABVC BioPharma inks licensing agreement with OncoX; expecting aggregate income of $13.75 mn and royalties of up to $12.50 mn
- Editorial Comments: looking for some innovative diagnostic or developmental research studies that might influence our laboratory and clinical decision-making
- Machine Learning as a Diagnostic and Prognostic Tool for Predicting Thrombosis in Cancer Patients: A Systematic Review